Tysana Pte Ltd Report issue

For profit Phase 1
Founded: Singapore Singapore (2018)
Status: No NME R&D (2018)

Organization Overview

First Clinical Trial
2018
NCT03776786
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Tysana Pte Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

ty014 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fever (Phase 1)

Virus Diseases (Phase 1)

Yellow Fever (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1